$ABUS
Arbutus Biopharma Corporation Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$5.07
▲+0.00%+$0.000
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateArbutus Biopharma Corporation Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is ABUS up today? It is at $5.07 (+0.00%), and our scanner flagged it 122 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ABUS spikes, and full due diligence on ABUS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ABUS 122 times in the last 30 days. Create a free account to track $ABUS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ABUS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ABUS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Androski Lindsay Officer | Acquired (grant/award) | +28K 0.01% of company | n/a | 28K | n/a | Feb 2, 26 |
Nguyen Tuan Officer | Acquired (grant/award) | +74K 0.04% of company | n/a | 74K | n/a | Feb 2, 26 |
Sims Karen Officer | Acquired (grant/award) | +49K 0.02% of company | added 46% | 155K | n/a | Feb 14, 25 |
Hastings David C Officer | Acquired (grant/award) | +90K 0.05% of company | added 56% | 250K | n/a | Feb 14, 25 |
Mcelhaugh Michael J. Officer | Acquired (grant/award) | +177K 0.09% of company | added 12% | 1.66M | n/a | Feb 14, 25 |
Naftzger J. Christopher Officer | Acquired (grant/award) | +54K 0.03% of company | added 63% | 141K | n/a | Feb 14, 25 |
Naftzger J. Christopher Officer | Sold (automatic/other) | -11K | sold 12% | 86K | $37K at $3.28 | Feb 4, 25 |
Mcelhaugh Michael J. Officer | Sold (automatic/other) | -24K 0.01% of company | sold 1.6% | 1.48M | $78K at $3.28 | Feb 4, 25 |
Sims Karen Officer | Sold (automatic/other) | -19K | sold 15% | 106K | $63K at $3.28 | Feb 4, 25 |
Hastings David C Officer | Sold (automatic/other) | -22K 0.01% of company | sold 12% | 160K | $73K at $3.28 | Feb 4, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on ABUS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ABUS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ABUS last traded at $5.07, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The ABUS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ABUS 122 times in the last 30 days.
ABUS (Arbutus Biopharma Corporation Common Stock) trades on XNAS, with a market cap of about $999M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ABUS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ABUS discussion
Sign in to ask a question or join the discussion.